AI-Generated Summary

NKGen Biotech issued a statement clarifying why its stock is displayed as $0.00 on certain financial websites, explaining it's due to its recent move to the OTC Expert Market. This situation resulted from the company's failure to meet SEC filing requirements, not a change in its underlying fundamentals. NKGen is actively working to regain compliance by completing its overdue financial reports.

In a nutshell

This situation underscores the critical importance of financial regulatory compliance for public biotechnology companies and its direct implications for market transparency and investor access to real-time information. It serves as a reminder of the operational challenges that can impact even clinical-stage innovators.

Source: GlobeNewswire